Cerebras

About

• US-based ML Accelerator company
• Raised $720 million so far, with $250 million raised in 2021.

Product

Adoption

• National Labs: Argonne National Laboratory, Lawrence Livermore National Lab
• Drug: GlaxoSmithKline, AstraZeneca
• Chip-making : Tokyo Electron

Architecture

Advantages

See Also

• Groq | Graphcore | SambaNova | Cerebras | Habana labs
• NVIDIA | AMD